Viewing

Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia. (Oncogene, Oct 2018)

Chong PSY1, Zhou J1,2, Chooi JY2, Chan ZL1, Toh SHM1, Tan TZ1, Wee S3, Gunaratne J3,4, Zeng Q3, Chng WJ5,6,7. Author information 1Cancer Science Institute of Singapore, National University of Singapore, Singapore. 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 3Institute of Molecular and Cell Biology, A*STAR, Singapore. 4Department of Anatomy, Yong Loo Lin School of Medicine, National

Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. (Nat Commun, Oct 2018)

Pitt JJ1,2, Riester M3, Zheng Y4, Yoshimatsu TF4, Sanni A5, Oluwasola O6, Veloso A3, Labrot E3, Wang S4,7, Odetunde A8, Ademola A9, Okedere B8, Mahan S3, Leary R3, Macomber M3, Ajani M6, Johnson RS3, Fitzgerald D1, Grundstad AJ1, Tuteja JH1, Khramtsova G4, Zhang J4, Sveen E4, Hwang B3, Clayton W4, Nkwodimmah C9, Famooto B9, Obasi E5, Aderoju V10, Oludara M10, Omodele F10, Akinyele O4, Adeoye A6, Ogundiran T9, Babalola C8,11, MacIsaac K3, Popoola A12, Morrissey MP3, Chen LS13, Wang J13, Olopade CO4, Falusi AG8, Winckler W3, Haase K14, Van Loo P14,15, Obafunwa J5, Papoutsakis D3, Ojengbede O16, Weber B3, Ibrahim N10, White KP17, Huo D18,19, Olopade OI20,21, Barretina

The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis. (J Pathol, Sep 2018)

Xiao JF1, Sun QY1, Ding LW1, Chien W2, Liu XY1, Mayakonda A1, Jiang YY1, Loh XY1, Ran XB1, Doan NB3, Castor B3, Chia D4, Said JW3, Tan KT1, Yang H1, Fu XY1,5, Lin DC2, Koeffler HP1,2. Author information 1Cancer Science Institute of Singapore, National University of Singapore, Singapore. 2Division of Hematology/Oncology, Cedar-Sinai Medical Center, UCLA School of Medicine, Los Angeles, CA, USA. 3Department of Pathology, University of California, Los Angeles, CA, USA.